Pulmonology

The ProAir Digihaler, from Teva, will reach the US markets widescale in 2020 after receiving FDA approval.

A new survey study found that less than half of food allergies reported by adults have actually been diagnosed by a physician.

A single blood eosinophil measurement may not be adequate for determining whether an asthma patient can have elevated blood eosinophils.

With no distinctive definition for what constitutes asthma-COPD overlap, clinicians are advising both diseases become diagnosed and treated differently.

Children often develop food allergies prior to developing asthma, and the former condition is associated with a greater risk of the latter condition in later life.

Children with asthma were less likely to have an ER visit if their families received greater SNAP benefits than if their family received a smaller benefit.

Living in rural areas and coal burning for heat were found to be risk factors for developing COPD.

African-American patients with moderate or severe sleep apnea have twice, or 3.5 times, the risk of resistant hypertension, respectively.

Pulmonary rehab is a program of exercise and education that is proven to increase exercise capacity, reduce symptoms, and elevate quality of life for patients, and is recommended in all major professional society guidelines in the US, Europe, and Canada.

The Regeneron Pharmaceuticals and Sanofi-collaborated biologic became a tour de force in pulmonological care in 2019.

The Spiration Valve System treats emphysema by blocking air from entering diseased areas of the lung.

The FDA has accepted a Biologics License Application as well as granted Priority Review for the gene therapy that treats spinal muscular atrophy (SMA) Type 1.

Patients frequently report not receiving sufficient information about COPD and how to manage it, investigators noted.